No photo of Mart Saarma

Mart Saarma

  • PL 56 (Viikinkaari 5)

    00014

    Finland

  • Viikinkaari 5, Biocenter 2

    00790 Helsinki

    Finland

1991 …2040
If you made any changes in Pure these will be visible here soon.

Publications 1991 2019

Filter
Review Article
2017

Unconventional neurotrophic factors CDNF and MANF: Structure, physiological functions and therapeutic potential

Lindahl, M., Saarma, M. & Lindholm, P., Jan 2017, In : Neurobiology of Disease. 97, part B, p. 90-102 13 p.

Research output: Contribution to journalReview ArticleScientificpeer-review

2016

c-Abl Inhibitors Enable Insights into the Pathophysiology and Neuroprotection in Parkinson's Disease

Lindholm, D., Pham, D. D., Cascone, A., Eriksson, O., Wennerberg, K. & Saarma, M., 26 Oct 2016, In : Frontiers in aging neuroscience. 8, 6 p., 254.

Research output: Contribution to journalReview ArticleScientificpeer-review

Open Access
File

Current disease modifying approaches to treat Parkinson's disease

Lindholm, D., Mäkelä, J., Di Liberto, V., Mudo, G., Belluardo, N., Eriksson-Rosenberg, O. & Saarma, M., Apr 2016, In : Cellular and Molecular Life Sciences. 73, 7, p. 1365-1379 15 p.

Research output: Contribution to journalReview ArticleScientificpeer-review

Open Access
File

Glial cell line-derived neurotrophic factor family ligands and their therapeutic potential

Sidorova, Y. A. & Saarma, M., Jul 2016, In : Molecular Biology. 50, 4, p. 521-531 11 p.

Research output: Contribution to journalReview ArticleScientificpeer-review

2015

Prospects of Neurotrophic Factors for Parkinson's Disease: Comparison of Protein and Gene Therapy

Domanskyi, A., Saarma, M. & Airavaara, M., 1 Aug 2015, In : Human Gene Therapy. 26, 8, p. 550-559 10 p.

Research output: Contribution to journalReview ArticleScientificpeer-review

Therapeutic potential of the endoplasmic reticulum located and secreted CDNF/MANF family of neurotrophic factors in Parkinson's disease

Voutilainen, M. H., Arumäe, U., Airavaara, M. & Saarma, M., 21 Dec 2015, In : FEBS Letters. 589, 24, p. 3739-3748 10 p.

Research output: Contribution to journalReview ArticleScientificpeer-review

2008

Signalling mechanisms underlying development and maintenance of dopamine neurons

Andressoo, J-O. & Saarma, M., 2008, In : Current Opinion in Neurobiology. 18, 3, p. 297-306 10 p.

Research output: Contribution to journalReview ArticleScientificpeer-review

2007

GDNF family receptor complexes are emerging drug targets

Bespalov, M. M. & Saarma, M., 2007, In : Trends in Pharmacological Sciences. 28, 2, p. 68-74 7 p.

Research output: Contribution to journalReview ArticleScientificpeer-review

Neurotrophic factor receptor RET: structure, cell biology, and inherited diseases

Runeberg-Roos, P. & Saarma, M., 2007, In : Annals of Medicine. 39, p. 572-580 9 p.

Research output: Contribution to journalReview ArticleScientificpeer-review

2002

The GDNF family: Signalling, biological functions and therapeutic value

Airaksinen, M. S. & Saarma, M., 2002, In : Nature Reviews. Neuroscience. 3, p. 383-394 12 p.

Research output: Contribution to journalReview ArticleScientificpeer-review

1999

GDNF family neurotrophic factor signaling: Four masters, one servant?

Airaksinen, M. S., Titievsky, A. & Saarma, M., 1999, In : Molecular and Cellular Neuroscience. 13, p. 313-325 13 p.

Research output: Contribution to journalReview ArticleScientificpeer-review

1994

NEUROTROPHINS AND CILIARY NEUROTROPHIC FACTOR - THEIR BIOLOGY AND PATHOLOGY

SARIOLA, H., SAINIO, K., ARUMAE, U. & SAARMA, M., 1994, In : Annals of Internal Medicine. 26, p. 355-363 9 p.

Research output: Contribution to journalReview ArticleScientificpeer-review

1993

NEUROTROPHIN RECEPTORS IN KIDNEY DEVELOPMENT

SAARMA, M., SAINIO, K., MOSHNYAKOV, M., SAXEN, L. & SARIOLA, H., 1993, In : Journal of Neurochemistry. 61, p. S179-S179 1 p.

Research output: Contribution to journalReview ArticleScientificpeer-review